KRT7 and metastatic malignant neoplasm in the lymph nodes: There were no significant differences between the groups of CK7+ and CK7− patients with regards to the UICC stage, blood vessel invasion, lymphatic vessel invasion, lymph node metastasis, or the expression of other immunohistochemical markers.